Literature DB >> 6643633

Determination of salbutamol in plasma by high-performance liquid chromatography with fluorescence detection.

M J Hutchings, J D Paull, D J Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6643633     DOI： 10.1016/s0378-4347(00)84870-7

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of oral salbutamol controlled-release in Asian patients with asthma.

Authors:  W C Tan; H S Lee
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; T A Moreland; A D Struthers; G A Clark; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.

Authors:  D J Morgan; J D Paull; B H Richmond; E Wilson-Evered; S P Ziccone
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

4.  Pharmacokinetics and metabolism of salbutamol in premature labour.

Authors:  M J Hutchings; J D Paull; E Wilson-Evered; D J Morgan
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 5.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 6.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

7.  Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?

Authors:  Eloni T Rotta; Sérgio L Amantéa; Pedro E Froehlich; Adriana Becker
Journal:  Eur J Clin Pharmacol       Date:  2010-02-27       Impact factor: 2.953

8.  Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma.

Authors:  A Kamachi; M Munakata; Y Nasuhara; M Nishimura; Y Ohtsuka; M Amishima; T Takahashi; Y Homma; Y Kawakami
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

9.  Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; M K Charter; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.